Sexual Function After Three-Dimensional Conformal Radiotherapy for Prostate Cancer: Results From a Dose-Escalation Trial

International Journal of Radiation Oncology Biology Physics

Volumn 68, Issue 2, 2007, Pages 479-484

  van der Wielen, Gerard J ^a   van Putten, Wim L J ^a   Incrocci, Luca ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Conformal radiotherapy; Dose escalation; Erectile dysfunction; Prostate cancer; Sexual function

Indexed keywords

HORMONES; RADIOTHERAPY; THREE DIMENSIONAL; TUMORS;

CONFORMAL RADIOTHERAPY; DOSE-ESCALATION; ERECTILE DYSFUNCTION; PROSTATE CANCER; SEXUAL FUNCTION;

PATIENT MONITORING;

HORMONE; PHOSPHODIESTERASE V INHIBITOR;

AGED; ARTICLE; CANCER PATIENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ERECTILE DYSFUNCTION; FOLLOW UP; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE ADENOCARCINOMA; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL; SEXUAL BEHAVIOR; SEXUAL FUNCTION; SEXUAL SATISFACTION;

AGED; CHEMOTHERAPY, ADJUVANT; COITUS; HORMONES; HUMANS; IMPOTENCE; MALE; MASTURBATION; PENILE ERECTION; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL;

EID: 34247844653     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.12.015     Document Type: Article

References (29)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2006. CA Cancer J Clin 56 (2006) 106-130
2. Penson D.F. An update on randomized clinical trials in localized and locoregional prostate cancer. Urol Oncol 23 (2005) 280-288
3. Penson D.F., Feng Z., Kuniyuki A., et al. General quality of life 2 years following treatment for prostate cancer: What influences outcomes? Results from the prostate cancer outcomes study. J Clin Oncol 21 (2003) 1147-1154
4. Helgason A., Adolfsson J., Dickman P., et al. Distress due to unwanted side-effects of prostate cancer treatment is related to impaired well-being (quality of life). Prostate Cancer Prostatic Dis 1 (1998) 128-133
5. al-Abany M., Steineck G., Agren Cronqvist A.K., et al. Improving the preservation of erectile function after external beam radiation therapy for prostate cancer. Radiother Oncol 57 (2000) 201-206
6. Borghede G., and Hedelin H. Radiotherapy of localised prostate cancer. Analysis of late treatment complications. A prospective study. Radiother Oncol 43 (1997) 139-146
7. Chen C.T., Valicenti R.K., Lu J., et al. Does hormonal therapy influence sexual function in men receiving 3D conformal radiation therapy for prostate cancer?. Int J Radiat Oncol Biol Phys 50 (2001) 591-595
8. Turner S.L., Adams K., Bull C.A., et al. Sexual dysfunction after radical radiation therapy for prostate cancer: A prospective evaluation. Urology 54 (1999) 124-129
9. Zelefsky M.J., Cowen D., Fuks Z., et al. Long term tolerance of high dose three-dimensional conformal radiotherapy in patients with localized prostate carcinoma. Cancer 85 (1999) 2460-2468
10. Litwin M.S., Lubeck D.P., Henning J.M., et al. Differences in urologist and patient assessments of health related quality of life in men with prostate cancer: Results of the CaPSURE database. J Urol 159 (1998) 1988-1992
11. Incrocci L. Sexual function after external-beam radiotherapy for prostate cancer: What do we know?. Crit Rev Oncol Hematol 57 (2006) 165-173
12. Green H.J., Pakenham K.I., Headley B.C., et al. Quality of life compared during pharmacological treatments and clinical monitoring for non-localized prostate cancer: A randomized controlled trial. BJU Int 93 (2004) 975-979
13. American Society for Therapeutic Radiology and Oncology Consensus Panel. Consensus statement: Guidelines for PSA following radiation therapy. Int J Radiat Oncol Biol Phys 37 (1997) 1035-1041
14. Peeters S.T., Hoogeman M.S., Heemsbergen W.D., et al. Volume and hormonal effects for acute side effects of rectum and bladder during conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 63 (2005) 1142-1152
15. Partin A.W., Yoo J., Carter H.B., et al. The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol 150 (1993) 110-114
16. International Commission on Radiation Units and Measurements (ICRU). Report No. 50: Prescribing, recording and reporting photon beam therapy (1993), International Commission on Radiation Units and Measurements, Bethesda
17. Korfage I.J., Essink-Bot M.L., Madalinska J.B., et al. Measuring disease specific quality of life in localized prostate cancer: The Dutch experience. Qual Life Res 12 (2003) 459-464
18. Incrocci L., Madalinska J.B., Essink-Bot M.L., et al. Sexual functioning in patients with localized prostate cancer awaiting treatment. J Sex Marital Ther 27 (2001) 353-363
19. Potosky A.L., Reeve B.B., Clegg L.X., et al. Quality of life following localized prostate cancer treated initially with androgen deprivation therapy or no therapy. J Natl Cancer Inst 94 (2002) 430-437
20. Cella D.F., Tulsky D.S., Gray G., et al. The Functional Assessment of Cancer Therapy scale: Development and validation of the general measure. J Clin Oncol 11 (1993) 570-579
21. O'Leary M.P., Fowler F.J., Lenderking W.R., et al. A brief male sexual function inventory for urology. Urology 46 (1995) 697-706
22. Schag C.A., and Heinrich R.L. Development of a comprehensive quality of life measurement tool: CARES. Oncology 4 (1990) 135-138
23. Schover L.R., Friedman J.M., Weiler S.J., et al. Multiaxial problem-oriented system for sexual dysfunctions: An alternative to DSM-III. Arch Gen Psychiatry 39 (1982) 614-619
24. Waterhouse J., and Metcalfe M.C. Development of the sexual adjustment questionnaire. Oncol Nurs Forum 13 (1986) 53-59
25. Incrocci L., Hop W.C., and Slob A.K. Visual erotic and vibrotactile stimulation and intracavernous injection in screening men with erectile dysfunction: A 3 year experience with 406 cases. Int J Impot Res 8 (1996) 227-232
26. Slob A.K., Blom J.H., and van der Werff ten Bosch J.J. Erection problems in medical practice: Differential diagnosis with relatively simple method. J Urol 143 (1990) 46-50
27. Rosen R.C., Riley A., Wagner G., et al. The international index of erectile function (IIEF): A multidimensional scale for assessment of erectile dysfunction. Urology 49 (1997) 822-830
28. Korfage I.J., de Koning H.J., Roobol M., et al. Prostate cancer diagnosis: The impact on patients' mental health. Eur J Cancer 42 (2006) 165-170
29. Little D.J., Kuban D.A., Levy L.B., et al. Quality-of-life questionnaire results 2 and 3 years after radiotherapy for prostate cancer in a randomized dose-escalation study. Urology 62 (2003) 707-713